Correlation between 99Tcm-HMPAO-SPECT brain image and a history of decompression illness or extent of diving experience in commercial divers

Occupational and Environmental Medicine

Volumn 54, Issue 4, 1997, Pages 247-253

  Shields, T G ^a   Duff, P M ^a   Evans, S A ^a   Gemmell, H G ^b   Sharp, P F ^b   Smith, F W ^b   Staff, R T ^b   Wilcock, S E ^b  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

decompression illness; diving; HMPAO SPECT

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OXIME; TECHNETIUM COMPLEX;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DECOMPRESSION SICKNESS; DIVER; DIVING; EXPERIENCE; HISTOGRAM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OBSERVER VARIATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN DISEASE; CASE CONTROL STUDY; OCCUPATIONAL DISEASE; PREVALENCE; SCINTISCANNING;

ADULT; BRAIN DISEASES; CASE-CONTROL STUDIES; DECOMPRESSION SICKNESS; DIVING; HUMANS; OCCUPATIONAL DISEASES; ORGANOTECHNETIUM COMPOUNDS; OXIMES; PREVALENCE; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030611908     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.54.4.247     Document Type: Article

References (17)

1. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NTS, Gvozdanovic D, et al. Technetium-99m HM-PAO stereoisomer as potential agents for imaging cerebral blood flow: human volunteer studies. J Nucl Med 1986; 27:171-7.
2. m-HM-PAO for the diagnosis of dementia. Nucl Med Commun 1987;8:525-3.
3. Holman BL, Garada B, Johnson KA, Mendelson J, Hallgring E, Teoh SK, et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nucl Med 1992;33:1312-5.
4. Adkisson GH, Hodgson M, Smith F, Torok Z, Macleod MA, Sykes JJW, Strack C. Cerebral perfusion deficits in dysbaric illness. Lancet 1989;ii:119-21.
5. Adkisson GH, Hodgson M, Macleod MA, Sykes JJW, Pearson RR. Cerebral perfusion deficits in dysbaric illness: follow-up studies in 18 divers. Proc XVth Ann Meeting Euorpean Underwater and Baromedical Society (EUBS). Eilat: Israeli Navy Publications: 1989:55-60.
6. Macleod MA, Adkisson GH, Kemp PM. A follow-up study of cerebral perfusion deficits in dysbaric illnesses. Nucl Med Commun 1990;11:223.
7. 99M HMPAO SPECT and correlation of techniques [abstract 148]. Undersea Biomed Res 1990; 17(suppl):100.
8. Costa DC, Ell PJ. Case studies. In: Costa DC, Ell PJ, eds. Clinician's guide to nuclear medicine - brain blood flow in neurology and psychiatry. London: Churchill Livingstone, 1991:176.
9. m hexamethylpropylene amine oxime. Undersea Biomed Res 1991;18:421-31.
10. Harch PG, Gottlieb SP, Van Meter K, Staab PK. SPECT brain imaging in the diagnosis and treatment of type II DCS [abstract 52]. Undersea Biomed Res 1992; 19(suppl):42
11. Wilmshurst PT, O'Doherty MJ, Nunan TO. Cerebral perfusion deficits in divers with neurological decompression illness. Nucl Med Commun 1993;14:177-220.
12. Shields TG, Cattanach S, Duff PM, Evans SA, Wilcock SE. Investigation into possible contributory factors to decompression sickness in commercial air diving and the potential long-term neurological consequences. Sheffield: Health and Safety Executive, 1996. (Offshore Technology Report-OTO 96 953.)
13. 99-Hm-PAO in normal man. Nucl Med Commun 1986;7:647-58.
14. Ichise M, Crisp S, Ganguli N, Tsui S, Gray BG. A method of two-dimensional mapping of cortical perfusion by cylindrical transformation of HMPAO-SPECT data. Nucl Med Commun 1995;16:386-94.
15. m-HMPAO SPET. Nucl Med Commun 1995; 16:438-42.
16. Gonzalez RC, Wintz P. Texture. Digital image processing. 2nd ed. Reading, MA: Addison Wesley, 1987:414-23.
17. Macleod MA, Houston AS, Kemp PM, Francis TJR. The assessment of dysbaric induced cerebral perfusion defects in divers using voxel by voxel multivariate analysis [abstract 125]. Eur J Nucl Med 1994;21(suppl):34.